GNT Exberry Plant-Based Pet Products and US Ingredient Trends

Why GNT’s Exberry move matters for US pet product brands in 2026

“GNT launches plant-based pet food ingredients under Exberry brand” is more than a product launch headline. For brands selling Pet Products in the United States, it is a live signal that ingredient competition is moving decisively toward naturally derived color, cleaner sourcing narratives, and functional positioning that can survive FDA-regulated scrutiny. When an established ingredient company extends a well-known natural coloring platform into pet applications, it indicates confidence that pet brands are willing to pay for ingredients that improve both formulation and marketability.

This matters right now because the fastest growing pockets of the US pet market are not driven by basic kibble economics alone. They are being shaped by premiumization, “humanized” pet nutrition, wellness claims, transparent sourcing, and retailer pressure for better label quality. The anchor story also arrives alongside several reinforcing developments: Canidae has emphasized ingredient sourcing and farmer storytelling in its latest campaign, while Syensqo has introduced natural, humanized ingredients for pet food, both underscoring the same consumer demand pattern around trust, ingredient quality, and emotional brand proof.

For international suppliers planning global expansion into the US, the takeaway is straightforward: ingredient trends are no longer separable from market entry strategy. A color, protein, fiber, or functional additive has to work across four dimensions at once: formulation performance, regulatory fit, consumer comprehension, and retail readiness. Missing any one of those can stall a launch even when the science is sound.

At US Brand Launch, this is exactly where founders and commercial teams get tripped up. A novel ingredient may look strong in Europe or Asia but still fail in the US because of labeling limitations, state-level feed nuances, retailer documentation expectations, or e-commerce presentation gaps. That is why the Exberry headline deserves attention far beyond the ingredient trade press.

The 2026 US ingredient trends shaping pet product innovation

The US pet products market in 2026 is rewarding ingredients that can perform multiple jobs at once: support appearance, strengthen a premium claim, reduce formulation compromises, and fit consumer expectations around “recognizable” inputs. GNT’s Exberry extension reflects a broader push toward plant-derived ingredient systems that replace synthetic-looking options with marketable alternatives. In practice, that means color and appearance are no longer merely technical choices; they influence conversion, perceived quality, and compatibility with “natural” positioning.

Several adjacent launches reinforce the same direction. Enifer and Rovio Pet Foods have partnered on a functional dog treat using PEKILO mycoprotein, showing continued momentum for fermentation-derived and alternative protein formats. Proteine Resources launched a brand built to showcase its EntoPro ingredient, highlighting the continued commercial testing of insect-derived inputs. Seppic, meanwhile, introduced a six-formula pet care kit around SepiFriend ingredients, a reminder that pet products growth is broader than ingestibles and extends into topical care, grooming, and wellness-adjacent routines.

What ties these signals together is not novelty for novelty’s sake. The fastest growing ingredient zones in the US combine one or more of the following: digestibility, sustainability language, palatability support, visual appeal, simplified labels, and a stronger story for online merchandising. Even technical B2B ingredient launches are now designed with end-consumer storytelling in mind.

For new entrants, the key insight is that innovation now needs to be legible. If a US shopper, buyer, or regulator cannot quickly understand what an ingredient is, why it is there, and how it should be described, the launch gets harder. This is why visually intuitive and source-transparent ingredients are gaining traction.

How FDA realities shape ingredient strategy for market entry

The US market rewards ambition, but it punishes sloppy regulatory compliance. In pet products, brands typically need to think across FDA oversight, ingredient status, manufacturing controls, labeling rules, and, where applicable, state feed registration expectations. A plant-based ingredient launch may sound straightforward, but whether it can be used, named, and marketed as intended depends on its legal and technical pathway.

For pet food and treats, founders should distinguish between a compelling ingredient story and a compliant one. An ingredient can be well accepted in another country and still face hurdles in the United States if there is uncertainty around intended use, common or usual naming, safety basis, or support for nutritional and functional framing. This is especially relevant for newer proteins, fermentation derivatives, extracts, or color-bearing ingredients used to shape product appearance.

That creates a practical challenge for global expansion. Many overseas companies assume that if an ingredient is plant-based, it is automatically low-risk from a US compliance perspective. That is not a safe assumption. Questions may arise around source material, processing method, residual solvents, concentration levels, technical function, and whether marketing language drifts into drug-like territory. The more premium the claim set, the more carefully the compliance architecture needs to be built.

This is where a pre-launch discipline matters. US Brand Launch’s AI Label Compliance Analysis ($599) is useful for stress-testing packaging copy before artwork is finalized, especially for brands importing ingredient concepts from outside the US. Likewise, a US Market Snapshot ($349) can quickly show whether a concept is entering a crowded claims cluster or a more open white space. Compliance and demand validation should happen together, not sequentially.

A practical process for US ingredient-led pet product entry

1. Define the ingredient’s technical role. Is it providing color, protein, palatability, texture, preservation, fiber, or wellness support? The answer drives both formulation choices and permissible product messaging.
2. Map legal naming and ingredient status. Confirm how the ingredient can be declared and whether existing US pathways support the intended use in pet applications.
3. Pressure-test claims. Separate structure/function-style marketing language from prohibited disease or treatment implications. This is a common failure point in premium pet wellness launches.
4. Model shopper comprehension. If the ingredient sounds unfamiliar, build packaging and merchandising language that explains it without creating confusion or compliance exposure.
5. Audit channel fit. Amazon, Chewy-style ecosystems, specialty retail, and veterinarian-adjacent channels all respond differently to ingredient novelty and proof requirements.
6. Prepare evidence files. Keep substantiation, supplier documents, specifications, COAs, and sourcing records organized for retailer onboarding and regulatory review.
7. Localize the story. Translate overseas sustainability or provenance messaging into terms US buyers and consumers actually use and trust.

What US consumers actually want from pet ingredients

US consumer demand in pet products is often described with broad labels such as “premium,” “natural,” or “functional.” Those terms are too vague to guide a launch. What buyers and pet owners usually respond to is a more concrete bundle of signals: ingredients they can pronounce, sourcing they can visualize, benefits they can repeat, and product aesthetics that imply care and quality. GNT’s Exberry pet move fits that pattern because plant-based color ingredients support appearance while reinforcing a familiar source-based story.

The Canidae sourcing campaign is instructive here. By elevating farmer stories and ingredient provenance, the brand is responding to a market where trust has become part of the product itself. That does not only affect hero proteins. It affects every supporting ingredient that appears on pack, in product detail pages, or in social creative. A premium formulation can lose momentum if one or two ingredients create a “what is that?” reaction in a high-consideration buyer.

Another important shift in 2026 is the continued “humanization” of pet nutrition and care. The Syensqo launch reported by Pet Food Processing reflects an industry belief that pet owners increasingly evaluate ingredients through the same lens they use for their own health, beauty, and wellness purchases. That does not mean every pet product should mimic human food trends. It means ingredients must increasingly satisfy expectations around source quality, naturalness cues, and emotional reassurance.

For marketers, this changes briefing standards. Ingredient selection is no longer the sole domain of R&D and procurement. Brand, regulatory, sales, and marketplace teams need to be involved earlier because the ingredient list itself is now part of acquisition strategy. In many categories, especially treats, toppers, supplements, and premium grooming, the ingredient panel is doing active selling work.

Where the biggest opportunities are for founders and international suppliers

The best US opportunities in 2026 are rarely in broad undifferentiated pet food launches. They tend to be in focused propositions where ingredient choice clearly supports a premium point of view. That includes functional treats, visually distinctive soft chews, topper formats, digestive health concepts, sensitive-pet formulations, limited-ingredient positioning, and cross-category pet care products with ingredient-led claims. The Exberry development points especially toward segments where product appearance matters commercially, whether for treat appeal, owner perception, or merchandising consistency.

International ingredient suppliers also have an opening to move from commodity supply to strategic partnership. If you can provide not just an ingredient, but also documentation, claim guidance, formulation support, and retail-facing storytelling assets, you become easier for US brands to onboard. The market increasingly values ingredient vendors who can reduce launch friction. The technical sale and the commercial sale are converging.

There is also room for “bridge” products that help acclimate the US market to newer inputs. Rather than launching an unfamiliar ingredient in a core maintenance food, brands may find better traction in treats, trial sizes, limited seasonal runs, or co-branded concept lines. This is particularly relevant for mycoprotein, insect ingredients, and unfamiliar fermentation-derived inputs. Lower-risk entry formats create consumer data before wider rollout.

For companies evaluating timing, the smartest move is often to commission a fact-based go/no-go assessment before significant packaging, inventory, or broker spend. US Brand Launch’s full US Launch Report ($599) can help benchmark demand, channel fit, white space, and friction points, while an Amazon Listing Audit can show how similar ingredient stories are winning or failing in digital shelves. For brands where IP, messaging consistency, and internal market files matter, BrandVault is useful for organizing launch intelligence centrally.

Common mistakes brands make when importing ingredient trends into the US

• Assuming plant-based automatically means easy compliance. Source, process, intended use, and claims still matter.
• Leading with novelty instead of clarity. If consumers do not understand the ingredient’s role, conversion suffers.
• Overusing wellness language. Pet owners like functional benefits, but unsupported therapeutic implications create FDA risk.
• Ignoring visual merchandising. Ingredients that improve product appearance can have outsized impact online and in-store, but only if supported by compliant messaging.
• Failing to localize sourcing narratives. Provenance stories that work abroad may sound abstract or unconvincing to US retailers and shoppers.
• Skipping channel-specific proof. What wins in specialty pet retail may not work on Amazon, and vice versa.
• Underestimating documentation demands. US buyers often want traceability, specs, substantiation, and manufacturing confidence before taking on a new ingredient story.

One additional mistake is treating “natural” as a complete strategy. In the United States, naturalness cues can help, but they do not replace the need for a concrete benefit, a strong value argument, and a packaging hierarchy that communicates quickly. A natural color ingredient may support premiumization, but the brand still needs to explain why the shopper should care.

Another frequent issue is weak internal alignment. Regulatory may approve one claim set, marketing may embellish it for social or Amazon bullets, and sales may pitch retailer benefits that do not match the pack. Ingredient-led brands need one source of truth for naming, benefits, substantiation, and restricted language. Without that, compliance drift becomes almost inevitable as the launch scales.

How to build a winning 2026 US pet ingredient strategy

Brands should think in layers. First, identify the consumer problem or desire: digestibility, cleaner label perception, visual quality, sustainability reassurance, or premium wellness. Second, choose ingredients that genuinely support that outcome. Third, validate whether the ingredient story is compliant and understandable in the US. Fourth, design packaging and digital content that translate technical value into purchase motivation. GNT’s Exberry launch is a reminder that even seemingly simple ingredient categories such as color can become strategic when they answer both technical and market-facing needs.

A strong strategy also accounts for speed. The US pet category moves quickly, but reformulation and relabeling are expensive. It is far better to enter with disciplined assumptions than to fix a mispositioned ingredient story after retailer meetings or marketplace reviews reveal the problem. Founders should use early intelligence to avoid dead-end claims, crowded angles, and sourcing narratives that do not travel well.

Finally, remember that US success depends on execution detail. The most promising ingredient trends in 2026 are not just those that are new; they are those that can be operationalized with clear compliance, persuasive storytelling, and channel-ready merchandising. Plant-based pet food ingredients under an established brand like Exberry signal where the market is heading: toward ingredients that help brands say more with less, look better without synthetic baggage, and meet rising consumer demand for transparency.

If you are evaluating a US market entry, reformulation, or expansion strategy for Pet Products, get a personalized US Launch Intelligence Report or start with a free Brand Readiness Score. That will show whether your ingredient story is built for the realities of the United States market before you commit serious budget.